The COVID-19 Coronavirus Leads to Acute Respiratory Distress Syndrome (ARDS) Post author:Shahid Ahmad Post published:March 20, 2020 Post category:Uncategorized An article in USA Today describes certain risks associated with contraction of the COVID-19 coronavirus, specifically the major cause of lethality being Acute Respiratory Distress Syndrome (ARDS). The article can be viewed here. You Might Also Like Vasomune Announces Preliminary Positive Phase 1 Clinical Trial Results for Vascular Normalization Therapy March 25, 2021 Vasomune Announces Initiation of the First-in-Human Clinical Trial of a Potential Vascular Normalization COVID-19 Treatment December 17, 2020 A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All June 13, 2015
Vasomune Announces Preliminary Positive Phase 1 Clinical Trial Results for Vascular Normalization Therapy March 25, 2021
Vasomune Announces Initiation of the First-in-Human Clinical Trial of a Potential Vascular Normalization COVID-19 Treatment December 17, 2020